Shares Magazine
3,300.00p+125.00 (+3.94%)02 Jan 2025, 15:41
Jump to:
Bioventix PLC Fundamentals
| Company Name | Bioventix PLC | Last Updated | 2025-01-02 |
|---|---|---|---|
| Industry | Biotechnology | Sector | Healthcare |
| Shares in Issue | 5.220 m | Market Cap | £172.25 m |
| PE Ratio | 20.77 | Dividend per Share | £1.58 |
| Dividend Yield | 4.88 | Dividend Cover | 0.97 |
| EPS | £1.53 | EPS Growth (%) | -0.02 |
| PEG | 0 | DPS Growth (%) | 0.1618 |
| Debt Ratio | 0 | Debt Equity Ratio | 0 |
| Asset Equity Ratio | 1.1440 | Cash Equity Ratio | 0.4998 |
| Quick Ratio | 7.0639 | Current Ratio | 7.42 |
| Price To Book Value | 14.3472 | ROCE | 0 |
Bioventix PLC Dividends
| Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
|---|---|---|---|---|---|
| Prelim | 2024-11-07 | 2024-11-21 | GBP | 0.8700 | |
| Interim | 2024-04-11 | 2024-04-26 | GBP | 0.6800 | |
| Prelim | 2023-11-09 | 2023-11-24 | GBP | 0.9000 | |
| Interim | 2023-04-06 | 2023-04-21 | GBP | 0.6200 | |
| Prelim | 2022-11-03 | 2022-11-18 | GBP | 0.7400 | |
| Interim | 2022-04-07 | 2022-04-22 | GBP | 0.5200 |
Bioventix PLC Company Financials
| Assets | 2024 | 2023 | 2022 |
|---|---|---|---|
| Tangible Assets | £477,997.00 | £575,726.00 | £694,370.00 |
| Intangible Assets | 0 | 0 | 0 |
| Investments | £426,733.00 | £610,039.00 | £610,039.00 |
| Total Fixed Assets | £904,730.00 | £1.19 m | £1.30 m |
| Stocks | £615,345.00 | £565,366.00 | £461,815.00 |
| Debtors | £6.21 m | £5.81 m | £5.22 m |
| Cash & Equivalents | £6.00 m | £5.72 m | £6.13 m |
| Other Assets | 0 | 0 | 0 |
| Total Assets | £13.73 m | £13.28 m | £13.12 m |
| Liabilities | 2024 | 2023 | 2022 |
|---|---|---|---|
| Creditors within 1 year | £1.73 m | £1.20 m | £1.25 m |
| Creditors after 1 year | 0 | £18,224.00 | £44,276.00 |
| Other Liabilities | 0 | 0 | 0 |
| Total Liabilities | £1.73 m | £1.22 m | £1.30 m |
| Net assets | £12.00 m | £12.06 m | £11.82 m |
| Equity | 2024 | 2023 | 2022 |
|---|---|---|---|
| Called up share capital | £260,983.00 | £260,983.00 | £260,467.00 |
| Share Premium | £1.47 m | £1.47 m | £1.33 m |
| Profit / Loss | £10.60 m | £10.13 m | £9.28 m |
| Other Equity | £12.00 m | £12.06 m | £11.82 m |
| Preference & Minorities | 0 | 0 | 0 |
| Total Capital Employed | £12.00 m | £12.06 m | £11.82 m |
| Ratios | 2024 | 2023 | 2022 |
|---|---|---|---|
| Debt Ratio | 0 | 0 | 0 |
| Debt-to-Equity | 0 | 0 | 0 |
| Assets / Equity | 1.1440 | 1.1440 | 1.1440 |
| Cash / Equity | 0.4998 | 0.4998 | 0.4998 |
| EPS | £1.58 | £1.61 | £1.47 |
| Cash Flow | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash from operating activities | £8.34 m | £7.80 m | £7.56 m |
| Cashflow before financing | £97,079.00 | -£501,342.00 | -£361,383.00 |
| Increase in Cash | £283,134.00 | -£410,831.00 | -£368,335.00 |
| Income | 2024 | 2023 | 2022 |
|---|---|---|---|
| Turnover | £13.61 m | £12.82 m | £11.72 m |
| Cost of sales | £925,527.00 | £828,410.00 | £710,446.00 |
| Gross Profit | £12.68 m | £11.99 m | £11.01 m |
| Operating Profit | £10.58 m | £10.03 m | £9.27 m |
| Pre-Tax profit | £10.60 m | £10.13 m | £9.28 m |
Bioventix PLC Company Background
| Sector | Healthcare |
|---|---|
| Activities | Bioventix PLC is a biotechnology company based in the United Kingdom. It specializes in the creation and supply of high-affinity sheep monoclonal antibodies and clinical diagnostics and drug abuse testing. The company's portfolio of products includes drugs that are applicable in the areas of cardiology, fertility, infectious diseases, Thyroid, and vitamin D disorder among others. It earns maximum revenue from European country. |
| Latest Interim Date | 25 Mar 2024 |
| Latest Fiscal Year End Date | 28 Oct 2024 |
Bioventix PLC Directors
| Appointed | Name | Position |
|---|---|---|
| 2024-12-24 | Mr. Bruce Edward Heath Hiscock | Executive Director,Chief Financial Officer |
| 2024-11-11 | Mr. Ian James Nicholson | Non-Executive Director,Chairman |
| 2024-11-11 | Mr. Peter John Harrison | Executive Director,Chief Executive Officer |
| 2020-07-01 | Ms. Treena Joan Turner | Non-Executive Director,Finance Director |
| 2024-11-11 | Mr. Nicholas John McCooke | Non-Executive Director |
Bioventix PLC Contact Details
| Company Name | Bioventix PLC |
|---|---|
| Address | 27-28 Eastcastle Street, London, W1W 8DH |
| Telephone | +44 1252728001 |
| Website | https://www.bioventix.com |
Bioventix PLC Advisors
| Solicitor | Charles Russell Speechlys LLP |
|---|---|
| Phone | +44 2072035000 |
| Nominated Adviser | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2072200597 |
| Auditor | James Cowper Kreston |
|---|---|
| Phone | +44 1189590261 |
| Stockbroker | FinnCap |
|---|---|
| Phone | +44 2072200500 |
| Fax | +44 2072200597 |
| Registrar | Share Registrars Limited |
|---|---|
| Phone | +44 1252821390 |
| Fax | +44 1252719232 |
Most Read
Receive our
daily news email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
| Company | Price | % Chg |
|---|---|---|
| Ithaca Energy PLC | 118.00 | 6.88 |
| Raspberry Pi Holdings PLC | 662.00 | 5.92 |
| Endeavour Mining PLC | 1,495.00 | 4.91 |
| Fresnillo PLC | 649.50 | 4.51 |
| Ocado Group PLC | 315.20 | 4.27 |
| Marks And Spencer Group PLC | 389.30 | 3.68 |
Fallers
| Company | Price | % Chg |
|---|---|---|
| Plus500 LTD | 2,560.00 | -5.47 |
| Trainline PLC | 413.60 | -4.26 |
| Integrafin Holdings PLC | 331.00 | -4.20 |
| Foresight Group Holdings Limited | 398.00 | -3.16 |
| Marshalls PLC | 285.50 | -3.06 |
| B&M European Value Retail S.A. | 356.80 | -2.78 |
Risers/fallers data from previous trading day. Today's data available from 8:15am.